Reveal LINQ vs QFR
AI Verdict
Choose Reveal LINQ if…
Choose Reveal LINQ if you need long-term, continuous monitoring to diagnose intermittent or elusive cardiac arrhythmias, such as those suspected in cases of cryptogenic stroke or unexplained syncope. Its implantable nature and AI-powered detection are ideal for capturing infrequent events over an extended period, providing crucial diagnostic insights that might be missed by shorter-term monitoring methods.
View Reveal LINQ →Choose QFR if…
Choose QFR if you require AI-powered analysis of X-ray angiographic images to assess the functional significance of coronary artery lesions. This tool is best suited for cardiologists in the cath lab setting who need precise anatomical quantification and quantitative flow ratio (QFR) assessment to guide revascularization decisions.
View QFR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Reveal LINQ | QFR |
|---|---|---|
| Deployment | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. | On-premise (integrates into cath lab environment) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Reveal LINQReveal LINQ (Tool A) offers a patient-centric design with a minimally invasive implant and user-friendly remote monitoring for both patients and clinicians via a bedside monitor and mobile app, demonstrating high reported ease of use and convenience. QFR (Tool B), while integrated into cath lab systems, lacks specific public data on its user experience for clinicians.
Clinical Value
Reveal LINQReveal LINQ (Tool A) has strong clinical validation from multiple studies demonstrating its superior ability to detect clinically significant arrhythmias over long periods, directly impacting diagnosis and treatment for conditions like AF and cryptogenic stroke. While QFR (Tool B) offers valuable diagnostic aid in cath labs, recent studies have shown some inconsistencies in its diagnostic performance in routine practice compared to traditional methods.
Pricing & Value
TieBoth tools operate in the medical device/software space where pricing is typically opaque and negotiated directly with healthcare institutions, often involving insurance coverage. Without any public pricing information or comparative cost-effectiveness studies, it is impossible to determine a winner in this dimension.
Enterprise Readiness
Reveal LINQReveal LINQ (Tool A) benefits from the extensive resources, established regulatory compliance (FDA-cleared, HIPAA compliant), and global support network of Medtronic, a major medical device corporation, including a dedicated remote monitoring service and data management infrastructure. QFR Solutions bv (Tool B) appears to be a smaller entity with less publicly available information regarding its comprehensive enterprise readiness or explicit HIPAA compliance beyond its likely nature.
Innovation
TieBoth tools demonstrate significant innovation in their respective domains. Reveal LINQ (Tool A) excels in hardware miniaturization, long-term continuous monitoring, and AI for reducing false positives in arrhythmia detection. QFR (Tool B) showcases innovation in applying AI and deep learning to real-time angiographic image analysis for functional lesion assessment and 3D reconstruction.
Support & Docs
Reveal LINQMedtronic, as a large and established medical device company, offers extensive and well-documented support resources for Reveal LINQ (Tool A), including technical services, patient services, and comprehensive educational materials. There is no public information available regarding the support and documentation for QFR by QFR Solutions bv (Tool B).
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Reveal LINQ | QFR |
|---|---|---|
| Name | Reveal LINQ | QFR |
| Company | Medtronic | QFR Solutions bv |
| Description/Primary Function | Tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias. | FDA-cleared AI-powered medical software for the visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments, aiding cardiologists in lesion assessment. |
| Key AI Feature | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause). | AI-enabled end-diastolic frame selection; Deep learning for precise alignment of angiographic projections; Quantitative Flow Ratio (QFR) assessment. |
| Specialties | Cardiology, Neurology | Cardiology |
| Monitoring/Analysis Type | Continuous ECG monitoring for up to three years. | Visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments. |
Videos
Demos, reviews, and walkthroughs featuring Reveal LINQ and QFR.